In our study, we evidenced, at baseline, the over-inflammation (higher serum values of IL-1, IL-6, and TNF-α) in T2DM vs non-T2DM patients, and much more in non-SGLT2-I users vs SGLT2-I users. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.